Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity

References

• Hedley A, Ogden CL, Johnson CL, Carol MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999–2002. JAMA. 2004; 291: 2847–50
   PubMed Web of Science ®Google Scholar
• Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. New Engl J Med. 2004; 350: 2362–74
   PubMed Web of Science ®Google Scholar
• Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity. 2006; 14: 529–644
   PubMed Web of Science ®Google Scholar
• Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004; 10: 1–7
   Google Scholar
• Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000; 26: 76–80
   PubMed Web of Science ®Google Scholar
• Masud S, Ye S. The SAS Group. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003; 40: 773–80
   PubMedGoogle Scholar
• Buzzetti R, Petrone A, Caiazzo AM, et al. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr Res. 2005; 57: 138–40
   PubMed Web of Science ®Google Scholar
• Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes. 2003; 52: 1655–63
   PubMed Web of Science ®Google Scholar
• Trujillo ME, Scherer PE. Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005; 257: 167–75
   PubMed Web of Science ®Google Scholar
• Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the metabolic syndrome. Diabetes. 2002; 51: 2306–12
   PubMed Web of Science ®Google Scholar
• Qi L, Doria A, Manson JE, et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes. 2006; 55: 1512–6
   PubMed Web of Science ®Google Scholar
• Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis. 2006; 188: 231–44
   PubMed Web of Science ®Google Scholar
• Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007; 298: 1300–11
   PubMed Web of Science ®Google Scholar
• Guerra A, Rego C, Castro EM, Seixas S, Rocha J. Influence of apolipoprotein e polymorphism on cardiovascular risk factors in obese children. Ann Nutr Metab. 2003; 47: 49–54
   Google Scholar
• Parlier G, Thomas G, Bereziat G, Fontaine JL, Girardet JP. Relation of apolipoprotein E polymorphism to lipid metabolism in obese children. Pediatr Res. 1997; 41: 682–5
   Google Scholar
• Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. New Engl J Med. 1998; 338: 1650–6
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 128: 412–9
   Google Scholar
• Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366: 1267–78
   PubMed Web of Science ®Google Scholar
• Filippi E, Sentinelli F, Romeo S, et al. The adiponectin gene SNP +276G > T associates with early-onset coronary artery disease with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years). J Mol Med. 2005; 83: 711–9
   PubMed Web of Science ®Google Scholar
• Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002; 11: 2607–14
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cook NR, Cheng S, et al. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol. 2003; 23: 859–63
   PubMed Web of Science ®Google Scholar
• Berthier MT, Houde A, Côté M, et al. Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. J Lipid Res. 2005; 46: 237–44
   Google Scholar
• Cruz M, García-Macedo R, Garcia-Valerio Y, et al. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care. 2004; 27: 1451–3
   PubMed Web of Science ®Google Scholar
• Bacci S, Menzaghi C, Ercolino T, et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care. 2004; 27: 2015–20
   PubMedGoogle Scholar
• Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes. 2005; 54: 1607–10
   PubMed Web of Science ®Google Scholar
• Ghoussaini M, Meyre D, Lobbens S, et al. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet. 2005; 6: 11
   Google Scholar
• Kamel AF, Norgren S, Strigard K, et al. Age-dependent regulation of lipogenesis in human and rat adipocytes. J Clin Endo Metab. 2004; 89: 4601–6
   Google Scholar
• Kamel A, Norgren S, Ehrén H, Hildingsson, Marcus C. Antilipolytic effect of insulin and insulin receptor messenger RNA expression in adipocytes of infants, children, and adults. Pediatr Res. 1997; 41: 563–7
   Google Scholar
• Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurance of dysbetalipoproteinaemia in man. Nature. 1977; 269: 604–7
   PubMed Web of Science ®Google Scholar
• Dallongville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a metaanalysis. J Lipid Res. 1992; 33: 447–54
   Google Scholar
• Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998; 20: 284–7
   PubMed Web of Science ®Google Scholar
• Takata N, Awata T, Inukai K, et al. Pro12Ala substitution in peroxisome proliferator-activated receptor gamma 2 is associated with low adiponectin concentrations in young Japanese men. Metabolism. 2004; 53: 1548–51
   PubMedGoogle Scholar
• Yamamoto Y, Hirose H, Miyashita K, et al. PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism. 2002; 51: 1407–9
   PubMed Web of Science ®Google Scholar
• Mousavinasab F, Tahtinen T, Jokelainen J, et al. Effect of the Pro12Ala polymorphism of the PPARg2 gene on serum adiponectin changes. Endocrine. 2005; 27: 307–9
   Google Scholar
• Mousavinasab F, Tahtinen T, Jokelainen J, et al. Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men. Mol Genet Metab. 2005; 84: 344–8
   PubMed Web of Science ®Google Scholar
• Orio F, Jr, Palomba S, Cascella T, et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89: 5110–5
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji N, Meyre D, Lobbens S, et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes. 2006; 55: 545–50
   PubMed Web of Science ®Google Scholar
• Petrone A, Zavarella S, Caiazzo A, et al. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity. 2006; 14: 1498–1504
   Google Scholar
• Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002; 106: 143–60
   PubMed Web of Science ®Google Scholar